Preventing Doping in Sports: A Fight for Fair Play

High-Yield Executive Summary

• Doping in sports undermines fair competition, athlete health, and the integrity of orthopaedic care by promoting unsafe performance enhancement.
• Common doping agents include anabolic steroids, erythropoietin (EPO), stimulants, and peptide hormones, each with distinct musculoskeletal and systemic risks.
• Orthopaedic surgeons play a critical role in identifying doping-related injuries and counseling athletes on the long-term consequences of performance-enhancing drugs (PEDs).
• Prevention strategies hinge on education, early detection through clinical and biochemical screening, and collaboration with multidisciplinary anti-doping agencies.
• Surgical decision-making must consider the altered healing environment and increased complication risks in doped athletes, influencing implant choice and rehabilitation protocols.

Clinical Fundamentals

Relevant Anatomy and Biomechanics

The musculoskeletal system is the primary target of doping agents, which alter muscle mass, tendon integrity, bone metabolism, and vascular supply. Anabolic steroids increase muscle protein synthesis but may weaken tendons and ligaments, predisposing to rupture. Erythropoietin enhances oxygen delivery but increases blood viscosity, raising thromboembolic risk. Understanding these biomechanical alterations is essential for anticipating injury patterns and surgical challenges.

Epidemiology

Doping prevalence varies by sport, with higher rates in strength and endurance disciplines. Orthopaedic injuries related to doping include tendon ruptures, stress fractures, and delayed fracture healing. Epidemiological data reveal a correlation between PED use and increased musculoskeletal complications, necessitating vigilance in athlete evaluation.

Classification & Diagnosis

Classification Systems Relevant to Doping-Related Injuries

Diagnostic Pearls and Pitfalls

• Pearl: Elevated creatine kinase and liver enzymes may suggest anabolic steroid use in athletes presenting with musculoskeletal complaints.
• Pitfall: Misattributing tendon rupture in young athletes solely to trauma without considering PED-induced tissue fragility.
• Pearl: MRI is superior for detecting early stress reactions in doped athletes, who may underreport symptoms due to performance pressure.
• Pitfall: Overlooking hypercoagulability in EPO users presenting with limb pain or swelling, which may mimic musculoskeletal injury.

The Decision-Making Algorithm

Non-Operative vs. Operative Management Criteria

Non-operative management is favored in low-grade stress injuries and partial tendon tears without functional deficit. Operative intervention is indicated for complete ruptures, displaced fractures, and nonunions, especially when PED use compromises tissue quality.

Surgical Approach and Implant Selection Rationale

• Approach: Minimally invasive techniques reduce soft tissue disruption, critical in doped athletes with impaired healing.
• Implants: Use of biologically active implants (e.g., BMP-coated devices) may counteract anabolic steroid-induced healing delays.
• Fixation: Rigid fixation is preferred to withstand altered biomechanical stresses and facilitate early mobilization.

Surgical Mastery & Pearls

Conceptual Overview of Surgical Technique for Tendon Rupture in Doped Athletes

1. Exposure: Careful dissection to preserve compromised soft tissue.
2. Debridement: Remove necrotic or steroid-affected tendon tissue to healthy margins.
3. Repair: Use augmented suture techniques (e.g., Krackow stitch) with high-strength, non-absorbable sutures.
4. Reinforcement: Consider autograft or synthetic augmentation to compensate for poor tendon quality.
5. Closure: Layered closure with minimal tension to optimize healing.

Intraoperative Red Flags

• Friable tendon or bone tissue indicating PED-related degeneration.
• Unexpected bleeding or thrombosis risk in EPO users.
• Poor implant purchase due to altered bone density.

Technical Tips

• Preoperative planning should include assessment of PED history and laboratory screening.
• Employ intraoperative imaging to confirm fixation stability.
• Postoperative immobilization protocols must balance protection with early controlled motion to prevent stiffness.

Evidence-Based Synthesis

Landmark studies demonstrate that anabolic steroid use correlates with increased tendon rupture rates and impaired fracture healing, altering the natural history of musculoskeletal injuries. Recent randomized trials on BMP use in fracture nonunions suggest improved outcomes in compromised biological environments, relevant to doped athletes. However, data on optimal surgical strategies remain limited, with ongoing debate about the timing of intervention and rehabilitation intensity. Anti-doping education programs have shown efficacy in reducing PED use, indirectly improving surgical outcomes by preserving tissue integrity.

Pro-Tip

Master surgeons anticipate the systemic and local effects of doping on tissue quality and healing potential. Preoperative multidisciplinary evaluation, including endocrinology and hematology consultation, optimizes perioperative risk management. Intraoperatively, meticulous soft tissue handling and augmented repair techniques are paramount. Postoperative protocols should be individualized, emphasizing gradual loading and vigilant monitoring for complications such as infection, thrombosis, and delayed union. This holistic approach elevates patient outcomes beyond technical success to true surgical excellence in the fight for fair play.

Last Updated on January 26, 2026 by OrthoNet AI